Augmentin '125' and Hip joint replacement - a phase IV clinical study of FDA data

Summary:

Hip joint replacement is reported as a side effect among people who take Augmentin '125' (amoxicillin; clavulanate potassium), especially for people who are male, 40-49 old, have been taking the drug for 5 - 10 years also take Zometa, and have Osteoporosis.

The phase IV clinical study analyzes which people have Hip joint replacement when taking Augmentin '125'. It is created by eHealthMe based on reports of 10,373 people who have side effects when taking Augmentin '125' from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Hip joint replacement?

Hip joint replacement is found to be associated with 861 drugs and 1,062 conditions by eHealthMe. Check the latest studies of Hip joint replacement.

On Apr, 27, 2026

10,373 people reported to have side effects when taking Augmentin '125'.
Among them, 23 people (0.22%) have Hip joint replacement.

Could Augmentin '125' cause Hip joint replacement?

Among these 23 people:

How long have people been on Augmentin '125' when they have Hip joint replacement? *

What is the gender of people who have Hip joint replacement when taking Augmentin '125'? *

female: 13.04 %
male: 86.96 %

What is the age of people who have Hip joint replacement when taking Augmentin '125'? *

What are other drugs people take besides Augmentin '125'? *

What are other side effects people have besides Hip joint replacement? *

Weight Decreased: 20 people, 86.96%
Pain: 20 people, 86.96%
Anaemia (lack of blood): 19 people, 82.61%
Bone Disorder: 19 people, 82.61%
Deformity (disfigurement): 18 people, 78.26%
Osteonecrosis Of Jaw (death of bone of jaw): 17 people, 73.91%
Rib Fracture: 17 people, 73.91%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 17 people, 73.91%
Weakness: 13 people, 56.52%
Depression: 12 people, 52.17%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 10 people, 43.48%
Urinary Tract Infection: 2 people, 8.70%
Pain: 1 person, 4.35%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 1 person, 4.35%
Multiple Myeloma (cancer of the plasma cells): 1 person, 4.35%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.35%
Hot Flush (sudden feelings of heat): 1 person, 4.35%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 4.35%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 4.35%
Depression: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and have Hip joint replacement?

- Check whether Hip joint replacement is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Augmentin '125':

Augmentin '125' (10,452 reports)

Hip joint replacement treatments and more:

Hip joint replacement (20,106 reports)

How severe was Hip joint replacement and when was it recovered:

Hip joint replacement in Augmentin '125'

Expand to all the drugs that have ingredients of amoxicillin; clavulanate potassium:

Hip joint replacement and drugs with ingredients of amoxicillin; clavulanate potassium

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hip joint replacement:

Hip joint replacement (861 drugs)

Browse all the conditions that are associated with Hip joint replacement:

Hip joint replacement (1,062 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium (the active ingredients of Augmentin '125') and Augmentin '125' (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.